“…Each clone was analyzed in a killing assay using the Fc␥R ϩ P815 murine mastocytoma cell line in the presence of mAb recognizing either KIRs or C-type lectin inhibitory receptors at the effector-target ratio (E/T) of 20:1 or 2:1 to identify clones with inhibiting or activating forms of these HLA-I receptors, respectively. [1][2][3][10][11][12][13]22 Soluble HLA-I antigen preparations Soluble HLA-A2, -Cw3, and -Cw4 were prepared from culture supernatant of HLA-I-A Ϫ , -B Ϫ , -C Ϫ , and -G Ϫ 721.221 cells transfected with the corresponding HLA-I alleles 6,28,29 while soluble HLA non-A, -B, -C, and -G was prepared from culture supernatant of untransfected 721.221 cells by precipitation with ammonium sulfate, low-medium pressure chromatography, strong anionic and strong cationic ion exchange, and gel filtration as described 28,29 and purified by affinity chromatography on anti-HLA class I mAb W6/32 (10 mg/mL) coupled to cyanogen bromide-activated Sepharose 4B (Pharmacia). The purity of sHLA-I molecule preparations was analyzed by 1-dimensional polyacrylamide gel electrophoresis (PAGE) under nonreducing/nondenaturing (Figure 2A) or reducing/denaturing conditions (not shown) followed by silver staining.…”